|
Raymond W. Cohen served as Chairman of the Board from September 2005 to October 2006 and has continued to serve as a director since that time. Mr. Cohen has served as Chief Executive Officer and a director of Symphony Medical Inc. a company that develops therapies to treat atrial fibrillation and other cardiac abnormalities since May 2006. Prior to September 2005 Mr. Cohen was the Chief Executive Officer for Cardiac Science Inc. and a member of its Board of Directors since January 1997. In September 2003 he was named Chairman and CEO. Prior to 1997 Mr. Cohen was President of Diagnostic Monitoring a privately held manufacturer and international distributor of non-invasive cardiac monitoring devices and previously was Vice President Sales & Marketing of DM Software Inc. a developer of cardiac monitoring software. From 1988 to 1990 Mr. Cohen was president of BioAnalogics Inc. a publicly held development-stage medical company. From 1982 to 1988 Mr. Cohen was Vice President Sales and Marketing for Brentwood Instruments Inc. a publicly held cardiology products distribution company. Mr. Cohen holds a B.S. in Business Management from the State University of New York at Binghamton. | 